Sanara MedTech Inc.
جودة البيانات: 100%
SMTI
NASDAQ
Manufacturing
Measuring & Analyzing Instruments
KWD 19.78
▼
KWD 0.23
(-1.15%)
6 months return
—
Momentum
Neutral
5Y revenue growth
43.76%
النمو
Revenue Growth (5Y)
43.76%
أعلى من متوسط القطاع (1.92%)
Revenue (1Y)18.97%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
الجودة
Return on Equity
-180.81%
أقل من متوسط القطاع (-54.47%)
ROIC8.39%
Net Margin-36.43%
Op. Margin7.08%
الأمان
Debt / Equity
7.33
أعلى من متوسط القطاع (0.30)
Current Ratio1.80
Interest Coverage1.08
التقييم
PE (TTM)
-4.14
أقل من متوسط القطاع (-1.50)
P/B Ratio25.31
EV/EBITDA16.52
Dividend YieldN/A
Quick Summary
Key Takeaways
Short bullets derived from reported financials—not the AI summary above.
Revenue grew 43.76% annually over 5 years — strong growth
Debt/Equity of 7.33 — high leverage
Generating 2.16 M in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 24.79%
Capital efficient — spends only 4.49% of revenue on capex
Interest coverage of 1.08× — tight debt servicing
Price History
الاتجاهات المالية
السعر المستهدف للمحللين
محلل 1
Buy
+82.0%
upside to target
الحالي
KWD 19.78
Consensus Target
KWD 36.00
KWD 36.00
أدنى
KWD 36.00
أعلى
التوقعات
ربحية السهم المستقبلية
-KWD 1.17
الإيرادات المقدّرة
0.0
مفاجآت الأرباح
EPS
Reported
Estimate
Forecast
Next: Q1 2026
·
EPS Est: -KWD 0.04
·
Rev Est: 26.90 M
| Q12025 | Q22025 | Q32025 | Q42025 | Q1 '26 | Q2 '26 | |
|---|---|---|---|---|---|---|
| Reported | -KWD 0.41 | -KWD 0.23 | -KWD 3.52 | -KWD 0.19 | — | — |
| Estimate | -KWD 0.51 | -KWD 0.44 | -KWD 0.22 | KWD 0.11 | -KWD 0.04 | KWD 0.02 |
| المفاجأة | +18.81% | +47.73% | -1537.21% | -272.73% | — | — |
Growth
Rev 5Y: 43.76% · Earnings 1Y: N/A
Growth
Rev 5Y: 43.76% · Earnings 1Y: N/A| Revenue Growth (1Y) | 18.97% | Revenue Growth (3Y) | 25.96% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 43.76% | Earnings Growth (5Y) | N/A |
Profitability
ROE: -180.81% · Net Margin: -36.43%
Profitability
ROE: -180.81% · Net Margin: -36.43%| Revenue (TTM) | 103.12 M | Net Income (TTM) | -37.56 M |
| ROE | -180.81% | ROA | -44.23% |
| Gross Margin | 92.71% | Operating Margin | 7.08% |
| Net Margin | -36.43% | Free Cash Flow (TTM) | 2.16 M |
| ROIC | 8.39% | FCF Growth (3Y) | N/A |
Safety
D/E: 7.33 · Current: 1.80
Safety
D/E: 7.33 · Current: 1.80| Debt / Equity | 7.33 | Current Ratio | 1.80 |
| Interest Coverage | 1.08 | Asset Turnover | 1.21 |
| Working Capital | 13.87 M | Tangible Book Value | -18.55 M |
Dividends
Yield: N/A · Payout: N/A
Dividends
Yield: N/A · Payout: N/A| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
Valuation
P/E: -4.14 · EV/EBITDA: 16.52
Valuation
P/E: -4.14 · EV/EBITDA: 16.52| P/E Ratio | -4.14 | Forward P/E | N/A |
| P/B Ratio | 25.31 | P/S Ratio | 1.51 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | 16.52 | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | 1.39% | ||
| Market Cap | 155.66 M | Enterprise Value | 185.81 M |
Per Share
EPS: -4.36 · FCF/Share: 0.24
Per Share
EPS: -4.36 · FCF/Share: 0.24| EPS (Diluted TTM) | -4.36 | Revenue / Share | 11.25 |
| FCF / Share | 0.24 | OCF / Share | 0.74 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
Efficiency
FCF Conv: -5.75% · CapEx/Rev: 4.49%
Efficiency
FCF Conv: -5.75% · CapEx/Rev: 4.49%| CapEx / Revenue | 4.49% | FCF Conversion | -5.75% |
| SBC-Adj. FCF | -2.84 M | Growth Momentum | -24.79 |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 103.12 M | 86.67 M | 64.99 M | 45.84 M | 24.14 M |
| Net Income | -37.56 M | -9.66 M | -4.30 M | -7.94 M | -7.99 M |
| EPS (Diluted) | -4.36 | -1.14 | -0.52 | — | — |
| Gross Profit | 95.60 M | 78.53 M | 57.14 M | 39.48 M | 21.83 M |
| Operating Income | 7.30 M | -6.72 M | -4.22 M | -12.23 M | -7.38 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 5.07 M | 5.70 M | 4.13 M | 3.37 M | 558,704.0 |
| SG&A Expenses | 78.72 M | 76.56 M | 56.99 M | 45.98 M | — |
| D&A | 3.95 M | 4.92 M | 3.68 M | 2.37 M | 596,975.0 |
| Interest Expense | 6.76 M | 3.13 M | 475,783.0 | 284,746.0 | 711.0 |
| Income Tax | 48,380.0 | -48,380.0 | -5.84 M | -5.84 M | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 72.94 M | 88.09 M | 73.87 M | 61.04 M | 36.40 M |
| Total Liabilities | 67.01 M | 49.18 M | 29.28 M | 19.32 M | 6.24 M |
| Shareholders' Equity | 5.94 M | 39.40 M | 44.83 M | 41.83 M | 30.64 M |
| Total Debt | 45.97 M | 30.69 M | 9.69 M | — | — |
| Cash & Equivalents | 16.58 M | 15.88 M | 5.15 M | 8.96 M | 18.65 M |
| Current Assets | 33.54 M | 33.31 M | 19.01 M | 20.62 M | 24.61 M |
| Current Liabilities | 18.63 M | 15.29 M | 13.77 M | 12.81 M | 6.02 M |
مقارنة الأقران
مقابل وسيط قطاع Manufacturing (1605 نظير)
مقارنة بشركات مشابهة في Manufacturing
مقارنة الأقران
مقابل وسيط قطاع Manufacturing (1605 نظير) مقارنة بشركات مشابهة في Manufacturing| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | -4.1 | -1.5 |
| P/B | 25.3 | 1.6 |
| ROE % | -180.8 | -54.5 |
| Net Margin % | -36.4 | -41.5 |
| Rev Growth 5Y % | 43.8 | 1.9 |
| D/E | 7.3 | 0.3 |
{"event":"ticker_viewed","properties":{"ticker":"SMTI","listing_kind":"stock","pathname":"/stocks/smti","exchange":"NASDAQ","country":"US"}}